Protagonist Therapeutics (PTGX)

6.73 -0.04 (0.59%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (6/4/18 *Est.)
- Conference (12/12/2018)

Latest Headlines

Nomura/Instinet Starts Protagonist Therapeutics (PTGX) at Buy December 6, 2018 3:51 AM - StreetInsider Protagonist Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference December 5, 2018 7:00 AM - PR NewsWire Form 8-K Protagonist Therapeutics For: Nov 27 November 27, 2018 4:30 PM - SEC Filing Protagonist Therapeutics (PTGX) Announces New Development Candidate PN-10943 for the Treatment of IBD November 27, 2018 4:05 PM - StreetInsider Protagonist Therapeutics Announces New Development Candidate PN-10943 for the Treatment of Inflammatory Bowel Disease November 27, 2018 4:01 PM - PR NewsWire New Research Coverage Highlights American Public Education, Protagonist Therapeutics, TravelCenters of America, Five Prime Therapeutics, Red Robin Gourmet Burgers, and Hemisphere Media Group — Conso November 9, 2018 8:40 AM - Globe NewsWire Protagonist Therapeutics to Present at the Stifel 2018 Healthcare Conference Wednesday, Nov. 14 November 7, 2018 4:30 PM - PR NewsWire Form 10-Q Protagonist Therapeutics For: Sep 30 November 6, 2018 5:00 PM - SEC Filing Form 8-K Protagonist Therapeutics For: Nov 06 November 6, 2018 4:31 PM - SEC Filing Protagonist Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update November 6, 2018 4:23 PM - PR NewsWire Protagonist Therapeutics (PTGX) Reports Complete Phase 1 Clinical Trial of Oral IL-23 Receptor Antagonist PTG-200 November 6, 2018 7:21 AM - StreetInsider Protagonist Therapeutics Announces Completion of Phase 1 Clinical Trial of Oral IL-23 Receptor Antagonist PTG-200 November 6, 2018 7:00 AM - PR NewsWire Form 8-K Protagonist Therapeutics For: Oct 22 October 22, 2018 8:38 AM - SEC Filing Protagonist Therapeutics Presents Clinical Data from the PROPEL Study of PTG-100 in Ulcerative Colitis at United European Gastroenterology Week October 22, 2018 8:32 AM - PR NewsWire Protagonist Therapeutics (PTGX) Reports Acceptance of Late Breaking Abstract for PTG-100 at UEG October 8, 2018 7:15 AM - StreetInsider Protagonist Therapeutics Announces Acceptance of Late Breaking Abstract for PTG-100 at the United European Gastroenterology Week Meeting October 8, 2018 7:13 AM - PR NewsWire Pre-Open Movers 09/27: (CBMG) (PTGX) (HAIR) Higher; (GERN) (VERU) (BBBY) Lower (more...) September 27, 2018 9:33 AM - StreetInsider Protagonist Therapeutics (PTGX) Says Fast Track Designation Granted by FDA to Hepcidin Mimetic PTG-300 September 27, 2018 7:03 AM - StreetInsider Protagonist Therapeutics Announces Fast Track Designation Granted by U.S. FDA to Hepcidin Mimetic PTG-300 September 27, 2018 7:00 AM - PR NewsWire Form 424B3 Protagonist Therapeutics September 26, 2018 5:28 PM - SEC Filing Protagonist Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference Monday, Oct. 1 September 24, 2018 7:00 AM - PR NewsWire Form EFFECT Protagonist Therapeutics September 24, 2018 6:08 AM - SEC Filing Protagonist Therapeutics Reports Granting of Inducement Award September 19, 2018 7:00 AM - PR NewsWire Full Article List